This week in science: collaboration employs artificial intelligence to find anti-aging drugs; study seeks to uncover genetic components of complex neurological disorders; acquisition will allow mining of genomic databases with machine learning; researchers use the skin to deliver treatments for diseases such as Diabetes.
A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs. The company, Qrative — pronounced CURE-a-tive — in Cambridge, Massachusetts is starting off with $8.3 million raised in its first venture funding round.
A data science team tapped into smartphones of more than 717,000 people worldwide to capture the number of steps they take each day as an indicator of physical activity. Findings from the NIH-funded study by researchers at Stanford University in Palo Alto, California appear in yesterday’s issue of the journal Nature (paid subscription required).
BioShack was founded by Megan in early 2011 at the beginning of the open science movement and was one of the first biohackerspaces in the San Francisco Bay Area. It became a business incubator and think tank where bioneers and citizen scientists came together to build apps and hacks that better our world. The organization supported a DIY culture where information and technology were shared freely for the purpose of developing socially responsible solutions. Many of the projects here at D8A came out of that original idea accelerator and members of this “citizen science brigade” are still active in the community.